氯吡格雷和美托洛尔用于心肌梗死的试验（COMMIT）PPT.pptVIP

In patients treated with clopidogrel versus placebo, the rate of major (fatal and transfused) bleeding (0.4 vs 0.3%; p=NS) and the rate of ICH (0.2 vs 0.2%; p=NS) showed no significant excess1 Reference 1. Chen ZM et al. ACC 2005. The results for the composite endpoint were consistently seen in the different subgroups of patients and there was no significant heterogeneity found for all pre-specified subgroups (p=0.4) It should be noted that results were consistent based on the day of event as shown above Chen ZM. ACC 2005. 1. Chen ZM et al. ACC 2005. COMMIT/CCS-2：氯吡格雷75mg和美托洛尔用于心肌梗死的试验（C